This article is more than 5 years old. Information may no longer be current.

VIDEO: PCSK9 inhibitor access remains an issue, but assistance available

Issue: April 2018

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ORLANDO, Fla. — In this Cardiology Today video exclusive, Seth J. Baum, MD, FASPC, discusses barriers faced by health care professions for the prescription of PCSK9 inhibitors.

While barriers remain, Baum, chief medical officer of Excel Medical Clinical Trials, clinical affiliate professor of biomedical science at Florida Atlantic University in Boca Raton and president of the American Society of Preventative Cardiology, highlights new resources that may help increase access to PCSK9 inhibitors, including the launch of a new app from the ASPC that was unveiled at the American College of Cardiology Scientific Session.

Watch the video for more.